US EditionSai Parenterals Secures INR 50 Crore Equity Investment from Marquee Investors
Summary by StartupTalky
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Sai Parenterals Secures INR 50 Crore Equity Investment from Marquee Investors
Sai Parenterals Limited is pleased to announce the successful completion of an INR 50 crore equity investment round by a group of marquee investors. The capital will support the company’s growth plans for establishing its international footprint as it pursues its vision to become a global pharmaceutical company.Samarsh Capital, Vyom Partners, and funds associated with Blue Lotus Capital led the fundraising round. Mr. Anil Karusala, Managing Dire…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
